These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7526536)

  • 21. Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.
    Fleury MJ; Touzé A; Alvarez E; Carpentier G; Clavel C; Vautherot JF; Coursaget P
    Arch Virol; 2006 Aug; 151(8):1511-23. PubMed ID: 16508703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.
    Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P
    J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
    Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
    J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
    Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
    Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.
    Da Silva DM; Pastrana DV; Schiller JT; Kast WM
    Virology; 2001 Nov; 290(2):350-60. PubMed ID: 11883199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies.
    Christensen ND; Höpfl R; DiAngelo SL; Cladel NM; Patrick SD; Welsh PA; Budgeon LR; Reed CA; Kreider JW
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2271-6. PubMed ID: 7521393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.
    Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD
    Virol J; 2012 Feb; 9():52. PubMed ID: 22356831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene.
    Varsani A; Williamson AL; Jaffer MA; Rybicki EP
    Virus Res; 2006 Dec; 122(1-2):154-63. PubMed ID: 16938363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.
    Rose RC; Reichman RC; Bonnez W
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2075-9. PubMed ID: 8046412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes.
    Wang XM; Cook JC; Lee JC; Jansen KU; Christensen ND; Ludmerer SW; McClements WL
    J Gen Virol; 2003 Jun; 84(Pt 6):1493-1497. PubMed ID: 12771418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated neutralization in vivo of infectious papillomaviruses.
    Christensen ND; Kreider JW
    J Virol; 1990 Jul; 64(7):3151-6. PubMed ID: 1693698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
    Bryan JT; Jansen KU; Lowe RS; Fife KH; McClowry T; Glass D; Brown DR
    J Med Virol; 1997 Nov; 53(3):185-8. PubMed ID: 9365880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions.
    Smith JF; Brownlow M; Brown M; Kowalski R; Esser MT; Ruiz W; Barr E; Brown DR; Bryan JT
    Hum Vaccin; 2007; 3(4):109-15. PubMed ID: 17611417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1.
    White WI; Wilson SD; Palmer-Hill FJ; Woods RM; Ghim SJ; Hewitt LA; Goldman DM; Burke SJ; Jenson AB; Koenig S; Suzich JA
    J Virol; 1999 Jun; 73(6):4882-9. PubMed ID: 10233949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.
    Culp TD; Spatz CM; Reed CA; Christensen ND
    Virology; 2007 May; 361(2):435-46. PubMed ID: 17222883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies.
    Cowsert LM; Lake P; Jenson AB
    J Natl Cancer Inst; 1987 Nov; 79(5):1053-7. PubMed ID: 2446044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
    Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
    J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope.
    Sadeyen JR; Tourne S; Shkreli M; Sizaret PY; Coursaget P
    Virology; 2003 Apr; 309(1):32-40. PubMed ID: 12726724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.
    Christensen ND; Kreider JW; Kan NC; DiAngelo SL
    Virology; 1991 Apr; 181(2):572-9. PubMed ID: 1707567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.